Amgen
AMGN
#99
Rank
NZ$308.41 B
Marketcap
NZ$572.75
Share price
-3.02%
Change (1 day)
25.91%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Amgen (AMGN) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$94.77 Billion

According to Amgen's latest financial reports the company's total debt is NZ$94.77 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Amgen - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$106.56 B4.3%
2023-12-31NZ$102.17 B66.56%
2022-12-31NZ$61.34 B25.79%
2021-12-31NZ$48.76 B6.67%
2020-12-31NZ$45.71 B2.96%
2019-12-31NZ$44.40 B-12.22%
2018-12-31NZ$50.58 B1.65%
2017-12-31NZ$49.76 B-0.36%
2016-12-31NZ$49.94 B8.76%
2015-12-31NZ$45.92 B17.14%
2014-12-31NZ$39.20 B0.27%
2013-12-31NZ$39.09 B21.23%
2012-12-31NZ$32.24 B17.46%
2011-12-31NZ$27.45 B58.52%
2010-12-31NZ$17.31 B18.67%
2009-12-31NZ$14.59 B-16.77%
2008-12-31NZ$17.53 B20.17%
2007-12-31NZ$14.59 B14.07%
2006-12-31NZ$12.79 B120.96%
2005-12-31NZ$5.78 B-19.16%
2004-12-31NZ$7.16 B51.14%
2003-12-31NZ$4.73 B-21.8%
2002-12-31NZ$6.05 B679.19%
2001-12-31NZ$0.77 B6.79%
2000-12-31NZ$0.72 B18%
1999-12-31NZ$0.61 B-1.06%
1998-12-31NZ$0.62 B39.75%
1997-12-31NZ$0.44 B77.95%
1996-12-31NZ$0.25 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
NZ$105.64 B 11.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$88.61 B-6.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$41.42 B-56.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
NZ$43.30 B-54.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$11.44 B-87.93%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$119.34 B 25.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$79.50 B-16.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$4.47 B-95.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$73.79 B-22.13%๐Ÿ‡บ๐Ÿ‡ธ USA